Frequency and clinical significance of transition zone cancer in prostate cancer screening

Prostate

Volumn 30, Issue 2, 1997, Pages 130-135

  Reissigl, Andreas ^a   Pointner, Josef ^a   Strasser, Hannes ^a   Ennemoser, Othmar ^a   Klocker, Helmut ^a   Bartsch, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

prostate cancer; PSA screening; transition zone; transrectal ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SCREENING; CLINICAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; CARCINOMA IN SITU; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0031020854     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970201)30:2<130::AID-PROS8>3.0.CO;2-S     Document Type: Article

References (18)

1. Byar DG, Mostofi FK, Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 30:5-13, 1972.
2. Liavag I: The localization of prostatic carcinoma. Scand J Urol Nephrol 2:65, 1968.
3. McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Am J Surg Pathol 12:897-906, 1988.
4. McNeal JE, Price H, Redwine E, Freiha FS, Stamey TA: Stage A versus stage B adenocarcinoma of the prostate: Morphological comparison and biological significance. J Urol 139:61-65, 1988.
5. Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2:105-124, 1975.
6. Voges GE, Mc Neal JE, Redwine EA, Freiha FS, Stamey TA: The predictive significance of substaging stage A prostate cancer (A 1 versus A 2) for volume and grade of total cancer in the prostate. J Urol 147:858-863, 1992.
7. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl Med 324:1156-1161, 1991.
8. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RC, Lange PH: Screening for prostate carcinoma with prostate specific antigen. J Urol 147:841-845, 1992.
9. Reissigl A, Strasser H, Horninger W, Peschel R, Klocker H, Mayersbach P, Schönitzer D, Bartsch G: PSA als First-line-Screeningtest für das Prostatakarzinom - Ergebnisse aus Tirol. In Faul P (ed): "Screening des Prostatakarzinoms." Berlin: Springer Verlag, 1995, pp 229-233.
10. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Liber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270:860-864, 1993.
11. Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71-75, 1989.
12. Gleason DJ, Mellinger GT, Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64, 1974.
13. Lui PD, Terris MK, McNeal JE, Stamey TA: Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153:1000-1003, 1995.
14. Karakiewicz PI, Bazinet M, Trudel C, Aprikian AG, Aronson S, Nachabé M, Peloquin F, Dessureault J, Zheng W, Goyal M, Begin LR, Elhilali M: Value of systematic transition zone biopsies in early detection of prostate cancer. J Urol (Suppl.) 153:298A, 1995.
15. Greene DR, Wheeler TM, Egawa S, Dunn IK, Scardino PT: A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146:1069-1076, 1991.
16. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC: Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341-345, 1989.
17. McNeal JE, Bostwich DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA: Patterns of progression in prostate cancer. Lancet 1:60-63, 1986.
18. Ohori M, Dunn JK, Wheeler TM, Goto Y, Scardino PT: Is there really a difference between peripheral zone and transition zone prostate cancer? J Urol (Suppl.) 153: 517A, 1995.